ライフサイエンスコーパス: Wegener granulomatosis

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 the Birmingham Vasculitis Activity Score for Wegener granulomatosis).

2 lications for clinical care of patients with Wegener granulomatosis.

3 ulitis, such as microscopic polyangiitis and Wegener granulomatosis.

4 andomized, controlled trial in patients with Wegener granulomatosis.

5 better than mature-PR3-ANCA as a measure of Wegener granulomatosis activity.

6 Most aspects of the care of children with Wegener granulomatosis and microscopic polyangiitis are

7 the diagnosis of such types of vasculitis as Wegener granulomatosis and microscopic polyangiitis.

8 e with those of ELISA is highly specific for Wegener granulomatosis and related vasculitides even in

9 ceived cyclophosphamide for the treatment of Wegener granulomatosis and were followed for 0.5 to 27 y

10 Sarcoidosis, Wegener granulomatosis, and pseudorheumatoid nodules mus

11 In Europe, Wegener granulomatosis appears to be more common at high

12 LE), systemic sclerosis, Takayasu arteritis, Wegener granulomatosis, Behcet syndrome, and transplant

13 rombotic events (VTEs) have been observed in Wegener granulomatosis, but the incidence rate is not kn

14 Study of other vasculitides, such as Wegener granulomatosis, Churg-Strauss syndrome, and micr

15 atients with systemic lupus erythematosis or Wegener granulomatosis did not differ from patients with

16 The incidence rate of VTEs in Wegener granulomatosis is high when compared with availa

17 cific causes of orbital inflammation such as Wegener granulomatosis must be considered to prevent pot

18 the head and neck is most commonly caused by Wegener granulomatosis, natural killer/T-cell lymphomas,

19 Eligible patients had newly diagnosed AAV (Wegener granulomatosis or microscopic polyangiitis) and

20 to the 1990 ACR classification criteria for Wegener granulomatosis, polyarteritis nodosa, giant-cell

21 A 56-year-old man with a history of Wegener granulomatosis presented with 6 days of sinus co

22 els to guide the management of patients with Wegener granulomatosis remains controversial.

23 matory vasculitides is wide: For example, in Wegener granulomatosis the pattern ranges from cavitatin

24 The incidence of VTE among patients with Wegener granulomatosis was 7.0 per 100 person-years (95%

25 case series of the use of plasma exchange in Wegener granulomatosis was published.

26 An exacerbation of Wegener granulomatosis was the principal concern because

27 Finally, plasma exchange for Wegener granulomatosis with severe renal dysfunction app

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。